ELUT
ELUT
NASDAQ · Biotechnology

Elutia Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$0.99
+0.04 (+4.73%)
As of Feb 8, 2:19 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +1,021.5% upside
Low Target $6.75
Average Target $11.07
High Target $12.78
Current Price $0.99
Current
$0.99
Target
$11.07
$6.75 $11.07 avg $12.78
Scenario Analysis
Bear Case
$6.75
583.8%
Low target
Base Case
$11.07
+1,021.5%
Avg target
Bull Case
$12.78
+1,194.7%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$12.85
-92.3% from high
52-Week Low
$5.01
+-80.3% from low
Target vs 52W High
$11.07
-13.9% vs high
Next Earnings Report
Mar 4, 2026 · After Market Close
16d
until earnings
EPS Est: $-0.12
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
 Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
 Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
 Hold 42 48% $91.45 -54.5%